Press releases
-
-
-
Internal link ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025
-
-
-
-
-
-
-
-
-
Internal link ProQR Strengthens Leadership with Appointments of CFO and CMO to Support Next Phase of Growth
-
-
Internal link ProQR Announces Results for the Third Quarter of 2016
-
-
-
-
Internal link ProQR Announces Results for the Second Quarter of 2016
-
-
Internal link ProQR to Release Topline Data from Proof of Concept Study of QR-010 in Cystic Fibrosis Patients at NACFC
-
Internal link ProQR’s Drug Candidate QR-110 for Leber’s Congenital Amaurosis Type 10 Receives EMA and FDA Orphan Drug Designation
-
Internal link ProQR Announces Presentations at the European CF Conference and the JMP Life Science Conference
-
Internal link ProQR Announces Results for the First Quarter of 2016
-
-
Internal link ProQR Announces Annual Meeting of Shareholders